(Allergan plc)

	AGN latest price $236.7740 (-0.88%) ($234.7761 - $240.1810) on Tue. Nov. 4, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.63% (three month average)
RSI	88
Latest Price	$236.7740(-0.88%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.5% a day on average for past five trading days.
Weekly Trend	AGN advances 4% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(55%)    XBI(47%)    SPY(43%)    QQQ(42%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -0.815% in a week (0% probabilities).   VIXM(-32%)    TLT(-18%)    SHY(-7%)    UUP(-5%)    IGOV(-5%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.815% (StdDev 1.63%)
Hourly BBV	0 ()
Intraday Trend	-0.6%

5 Day Moving Average	$235.03(0.74%)
10 Day Moving Average	$232.26(1.94%)
20 Day Moving Average	$226.95(4.33%)
To recent high	-1.1%
To recent low	21%
Market Cap	$78.064b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed